Grants Archive - Page 173 of 180 - Kenneth Rainin Foundation

Immunosuppressive drugs and anti-inflammatory biologics are used to treat moderate-to-severe ulcerative colitis. Unfortunately, many patients suffer untoward effects, do not achieve remission and/or eventually relapse. Using a mouse model of colitis triggered by a pathogen of mice, we identified the host surface molecule B7-H3 as a suppressor of colonic inflammation. B7-H3 is thought to dampen […]

Mesenchymal cells are the building blocks of the connective tissue that provides rigidity and structural support for most organs. Although mesenchymal cells comprise the most abundant cell type in the intestine, their role in regulating intestinal inflammation is poorly understood. In this project we study the role of mesenchymal cells in colitis, the most prevalent […]

Inflammatory Bowel Disease (IBD) is associated with currently untreatable conditions such as fibrosis and strictures that arise as a consequence of aberrant wound healing. It is of utmost importance that we understand the biology of normal wound healing and discover why IBD is associated instead with abnormal wound healing. Immune cells called macrophages help sense […]

The microbes that colonize the human intestine, collectively known as the gut microbiome, are critical players in many human diseases including IBD. Patients with IBD often have fewer different types of intestinal bacteria and an increase in certain types of bacteria associated with inflammation. In addition to bacteria, there are many viruses that live in […]

Inflammatory bowel disease (IBD) is less common in parts of the world with parasitic worm infections than in the developed world. Understanding why may lead to new types of therapy. We recently found that infection by parasitic worms increases the number of beneficial anti-inflammatory Clostridiales bacteria in the intestine, and that these bacteria can outcompete […]

The intestinal microbiota is the collective term used to described the microbial community living in our intestine and playing important roles. However, the intestinal microbiota is also playing a central role in the development of many chronic inflammatory diseases, including inflammatory bowel disease (IBD). We previously reported, in mice, that the consumption of dietary emulsifiers, […]

So far, most research on the microbiome in IBD has mostly focused on gut bacteria. However, there is increasing evidence to support that other members of the microbiome, such as viruses, may also have an important role. Herein we plan to study the role of viral exposures in IBD development. A major challenge of this […]

The incidence of Inflammatory Bowel Disease is increasing worldwide in lockstep with modernization and worldwide ‘Westernization’ of lifestyles. One of the most important aspects of Westernization for human health is the adoption of a diet high in fat and sugar and low in fiber. Relatively little is known about how dietary sugar specifically affects the […]

Environmental factors are thought to contribute to the development of a range of human diseases, including inflammatory bowel disease (IBD) and autism spectrum disorder (ASD). Interestingly, the incidence of IBD is higher in patients with autism, compared to those without. We propose that inflammation to which a developing embryo may be exposed in the maternal […]

The gut is composed of many cell types that contribute to its complex functions and ability to adapt to changing conditions associated with diet, lifestyles and the environment. Each of these factors can affect the health of the gut and contribute to intestinal disease such as inflammatory bowel disease and intestinal discomfort and pain. Many […]